REG-4basebio Plc: Holding(s) in Company
06/02/2024 07:15
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BMCLYF79
Issuer Name
4BASEBIO PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights; An event changing the breakdown
of voting rights
3. Details of person subject to the notification obligation
Name
Wilhelm K. T. Zours
City of registered office (if applicable)
Heidelberg
Country of registered office (if applicable)
Germany
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the
notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
01-Feb-2024
6. Date on which Issuer notified
05-Feb-2024
7. Total positions of person(s) subject to the notification obligation
. % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 51.611829 0.000000 51.611829 6604357
Position of previous notification (if applicable) 52.587160 0.000000 52.587160
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BMCLYF79 6604357 51.611829
Sub Total 8.A 6604357 51.611829%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
Wilhelm K.T. Zours
Wilhelm K.T. Zours DELPHI Unternehmensberatung Aktiengesellschaft 4.989259 4.989259%
Wilhelm K.T. Zours Deutsche Balaton Aktiengesellschaft 7.415955 7.415955%
Wilhelm K.T. Zours SPARTA AG 10.563426 10.563426%
Wilhelm K.T. Zours 2invest AG 28.643189 28.643189%
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
13. Place Of Completion
Heidelberg, Germany
Copyright (c) 2024 PR Newswire Association,LLC. All Rights ReservedRecent news on 4Basebio
See all newsREG-4basebio Plc: 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program
AnnouncementREG-4basebio Plc: 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine
AnnouncementREG-4basebio Plc: 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence
AnnouncementREG-4basebio Plc: Directors' Dealings
AnnouncementREG-4basebio Plc: Holding(s) in Company
Announcement